register free | resend password

Medigene AG: Medigene participates at upcoming virtual conferences

ID: 1561083
recent pressrelease next pressrelease

(businesspress24) - Martinsried/ Munich (28.09.2020) - Medigene AG (FSE: MDG1, Prime Standard) today announces its participation at the following upcoming scientific and investor conferences. Please note that all mentioned conferences will be conducted virtually due to COVID-19.

Cell Therapy Manufacturing & Gene Therapy Congress
Date: 19 - 22 October

TCR Therapies Summit
Date: 26 - 29 October

BIO-Europe Digital
Date: 26 - 29 October

Neoantigen Based Therapies Summit
Date: 3 - 5 November

35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020)
Date: 9 - 14 November

62nd ASH Annual Meeting and Exposition
Date: 5 - 8 December

- end of announcement -

Medigene AG (FSE: MDG1, ISIN DE000A1X3W00, Prime Standard) is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative immunotherapies to target various forms and stages of cancer. Medigene concentrates on the development of personalized T cell-based therapies, with associated projects currently in pre-clinical and clinical development.

For more information, please visit

This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.

Contact Medigene AG
Dr Gary Waanders, Dr Anna Niedl
Tel.: +49 89 2000 3333 01
email: investor(at)


emitter: Medigene AG
address: Lochhamer Straße 11, 82152 Planegg/Martinsried
country: Germany
contact person: Medigene PR/IR
phone: +49 89 2000 3333 01
e-mail: investor(at)

ISIN(s): DE000A1X3W00 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate

More information:

Keywords (optional):

Company information / Profile:

PressRelease by


Die Medigene AG ist ein börsennotiertes Biotechnologie-Unternehmen mit Hauptsitz in Martinsried bei München.

PressContact / Agency:

published by: irw
print pressrelease  send to a friend  

Date: 09/28/2020 - 22:06
Language: English
News-ID 1561083
Character count: 2962
Firma: Medigene AG
Ansprechpartner: Feedback to about Pressrelease-id:
Stadt: Wien


Number of hits: 394


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 72

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.